Lutje V, Seixas J, Kennedy A: Chemotherapy for second-stage human African trypanosomiasis. Cochrane Database Syst Rev 2013;(6):CD006201.
Morillo CA et al: Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Engl J Med 2015;373:1295.
Murray HW: Leishmaniasis in the United States: Treatment in 2012. Am J Trop Med Hyg 2012;86:434.
Murray HW et al: Advances in leishmaniasis. Lancet 2005;366:1561.
Musa A et al: Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: A randomised controlled trial. PLoS Negl Trop Dis 2012;6:e1674.
Priotto G et al: Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: A multicentre, randomised, phase III, non-inferiority trial. Lancet 2009;374:56.
Rassi A Jr, Rassi A, Marcondes de Rezende J: American trypanosomiasis (Chagas disease). Infect Dis Clin North Am 2012;26:275.
Rassi A et al: Chagas disease. Lancet 2010;375:1388.
Rubiano LC et al: Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children. J Infect Dis 2012;205:684.
Sosa N et al: Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in Panama. Am J Trop Med Hyg 2013;89:557.
Sundar S et al: Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: An open-label, non-inferiority, randomised controlled trial. Lancet 2011;377:477.
Sundar S et al: Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clin Infect Dis 2012;55:543.
Sundar S et al: Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label study. PLoS Negl Trop Dis 2014;8:e3169.
Sundar S, Singh A: Recent developments and future prospects in the treatment of visceral leishmaniasis. Ther Adv Infect Dis 2016;3:98.
Sundar S et al: Single-dose liposomal amphotericin B for visceral leishmaniasis in India. N Engl J Med 2010;362:504.
van Griensven J, Diro E: Visceral leishmaniasis. Infect Dis Clin North Am 2012;26:309.
van Griensven J et al: Combination therapy for visceral leishmaniasis. Lancet Infect Dis 2010;10:184.
Vélez I et al: Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis. Am J Trop Med Hyg 2010;83:351.